SIOP has launched its new Strategic Plan for 2026–2030, setting out a clear framework to advance its vision that no child should die of cancer: cure for more, care for all.
Developed through a year-long, highly consultative process involving SIOP members, leaders, partners and stakeholders worldwide, the Strategy builds on the Society’s achievements over the past five years while responding to emerging challenges in childhood and adolescent cancer care, research, education and advocacy.
A Shared Vision
SIOP remains committed to improving survival rates, quality of survival and access to care for children and adolescents with cancer in all settings. While childhood cancer is highly curable in many high-income countries, major disparities persist globally. With the majority of the world’s children living in low- and middle-income countries, addressing inequities in diagnosis, treatment, research and survivorship remains a central priority.
The Strategic Plan 2026–2030 provides a practical and adaptable framework to support SIOP members and partners in driving progress at global, regional and national levels.
Five Strategic Goals for 2026–2030
The new Strategy retains five interdependent strategic goals that reflect SIOP’s core functions and global role:
- Advocating globally for children and adolescents with cancer
- Promoting research to improve outcomes for patients
- Providing education and training
- Increasing membership engagement and retention
- Strengthening and expanding strategic partnerships
Together, these goals reinforce SIOP’s position as a global convener, advocate and trusted source of expertise in paediatric oncology.
A Strong and Engaged Global Community
With more than 4,000 members in over 140 countries, SIOP enters the 2026–2030 period as a stronger and more diverse Society than ever before! The Strategy places renewed emphasis on meaningful member engagement, leadership development and recognition of the volunteer leaders who drive SIOP’s activities throughout the year.
Looking Ahead
By 2030, SIOP aims to be widely recognised as a trusted global leader in childhood cancer, a catalyst for collaborative research and a strong advocate for equitable access to high-quality care. Success will be measured not only by improved survival, but also by better quality of survival and strengthened health systems worldwide.
